Age-specific seroprotection after Hepatitis B virus vaccination among Korean American pediatric population in Queens, New York

References

• Liang TJ. Hepatitis B: the virus and disease. Hepatology. 2009;49(5 Suppl):S13–6. doi:10.1002/hep.22881.
   PubMed Web of Science ®Google Scholar
• McGlynn KA, Petrick JL, London WT. Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability. Clin Liver Dis. 2015;19(2):223–38. doi:10.1016/j.cld.2015.01.001.
   PubMed Web of Science ®Google Scholar
• WHO. Global hepatitis report, 2017. Geneva; 2017.
   Google Scholar
• CDC. Preventing Hepatitis B. 2017 [accessed 2018 Mar 30]. https://www.cdc.gov/globalhealth/immunization/othervpds/preventing_hepatitisb.html .
   Google Scholar
• Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386(10003):1546–55. doi:10.1016/s0140-6736(15)61412-x.
   PubMed Web of Science ®Google Scholar
• Moore MS, Bocour A, Laraque F, Winters A. A surveillance-based hepatitis C care cascade, New York City, 2017. Public Health Rep. 2018;133(4):497–501. doi:10.1177/0033354918776641.
   PubMed Web of Science ®Google Scholar
• Roberts H, Kruszon-Moran D, Ly KN, et al. Prevalence of chronic hepatitis B virus (HBV) infection in U.S. households: National Health and Nutrition Examination Survey (NHANES), 1988-2012. Hepatology. 2016;63(2):388–97. doi:10.1002/hep.28109.
   PubMed Web of Science ®Google Scholar
• Kim HS, Rotundo L, Yang JD, Kim D, Kothari N, Feurdean M, Ruhl C, Unalp-Arida A. Racial/ethnic disparities in the prevalence and awareness of hepatitis B virus infection and immunity in the United States. J Viral Hepat. 2017;24(11):1052–66. doi:10.1111/jvh.12735.
   PubMed Web of Science ®Google Scholar
• Tang AS, Lyu J, Wang S, He Q, Pong P, Harris AM. Disparities in hepatitis B virus infection and immunity among New York City Asian American patients, 1997 to 2017. Am J Public Health. 2018;108(S4):S327–s335. doi:10.2105/ajph.2018.304504.
   PubMedGoogle Scholar
• Asian Ddfabt CA. Profile of New York City’s Korean Americans. New York, NY: Asian Ddfabt, Center AFCI; Asian American Federation Census Information Center (CIC); 2013. p. 4.
   Google Scholar
• Weinbaum CM, Williams I, Mast EE, et al. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep. 2008;57(Rr–8):1–20.
   PubMedGoogle Scholar
• Hyun CS, Kim S, Kang SY, Jung S, Lee S. Chronic hepatitis B in Korean Americans: decreased prevalence and poor linkage to care. BMC Infect Dis. Aug 15 2016;16(1):415. doi:10.1186/s12879-016-1732-7.
   PubMedGoogle Scholar
• KCDC. Korea National Health and Nutrition Examination Survey (KNHANES). Korea Centers for Disease Control & Prevention; http://knhanes.cdc.go.kr2016 .
   Google Scholar
• WHO. Immunization coverage. Fact Sheet. [accessed 2020 Jul]. https://www.who.int/news-room/fact-sheets/detail/hepatitis-b2020 .
   Google Scholar
• Whittle HC, Inskip H, Hall AJ, Mendy M, Downes R, Hoare S. Vaccination against hepatitis B and protection against chronic viral carriage in the Gambia. Lancet. Mar 30 1991;337(8744):747–50. doi:10.1016/0140-6736(91)91367-4.
   PubMed Web of Science ®Google Scholar
• Chen HL, Chang MH, Ni YH, et al. Seroepidemiology of hepatitis B virus infection in children: Ten years of mass vaccination in Taiwan. Jama. 1996;276(11):906–08. doi:10.1001/jama.1996.03540110060032.
   PubMed Web of Science ®Google Scholar
• Wang LY, Hu CT, Ho TY, Lin HH. Geographic and ethnic variations of long-term efficacy and immunogenicity of hepatitis B vaccination in Hualien, a HBV hyperendemic area. Vaccine. 2006;24(20):4427–32. doi:10.1016/j.vaccine.2005.12.069.
   PubMed Web of Science ®Google Scholar
• Assad S, Francis A. Over a decade of experience with a yeast recombinant hepatitis B vaccine. Vaccine. 1999;18(1–2):57–67. doi:10.1016/s0264-410x(99)00179-6.
   PubMed Web of Science ®Google Scholar
• Venters C, Graham W, Cassidy W. Recombivax-HB: perspectives past, present and future. Expert Rev Vaccines. 2004;3(2):119–29. doi:10.1586/14760584.3.2.119.
   PubMedGoogle Scholar
• Leuridan E, Van Damme P. Hepatitis B and the need for a booster dose. Clin Infect Dis. 2011;53(1):68–75. doi:10.1093/cid/cir270.
   PubMed Web of Science ®Google Scholar
• Wu TW, Lin HH, Wang LY. Chronic hepatitis B infection in adolescents who received primary infantile vaccination. Hepatology. 2013;57(1):37–45. doi:10.1002/hep.25988.
   PubMed Web of Science ®Google Scholar
• Jack AD, Hall AJ, Maine N, Mendy M, Whittle HC. What level of hepatitis B antibody is protective? J Infect Dis. 1999;2:489–92. doi:10.1086/314578.
   Google Scholar
• Navabakhsh B, Mehrabi N, Estakhri A, Mohamadnejad M, Poustchi H. Hepatitis B virus infection during pregnancy: transmission and prevention. Middle East J Dig Dis. 2011;3(2):92–102.
   PubMedGoogle Scholar
• Hur YJ, Choe SA, Choe YJ, Paek J. Hepatitis B surface antigen and antibody positivity among women of childbearing age after three decades of universal vaccination in South Korea. Int J Infect Dis. 2021;104:551–55. doi:10.1016/j.ijid.2020.11.147.
   PubMed Web of Science ®Google Scholar
• Kushner T, Chen Z, Tressler S, Kaufman H, Feinberg J, Terrault NA. Trends in hepatitis B infection and immunity among women of childbearing age in the United States. Clin Infect Dis. Jul 27 2020;71(3):586–92. doi:10.1093/cid/ciz841.
   PubMed Web of Science ®Google Scholar
• WHO. Hepatitis B vaccines: WHO position paper, July 2017 - recommendations. Vaccine. 2019;37(2):223–25. doi:10.1016/j.vaccine.2017.07.046.
   PubMed Web of Science ®Google Scholar
• Are booster immunisations needed for lifelong hepatitis B immunity? European Consensus Group on Hepatitis B Immunity. Lancet. 2000;355(9203):561–65. doi:10.1016/S0140-6736(99)07239-6.
   PubMed Web of Science ®Google Scholar
• Samandari T, Fiore AE, Negus S, Williams JL, Kuhnert W, McMahon BJ, Bell BP. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy. Pediatrics. 2007;120(2):e373–81. doi:10.1542/peds.2007-0131.
   PubMed Web of Science ®Google Scholar
• Lu CY, Ni YH, Chiang BL, Chen P-J, Chang M-H, Chang L-Y, Su I-J, Kuo H-S, Huang L-M, Chen D-S, et al. Humoral and cellular immune responses to a hepatitis B vaccine booster 15–18 years after neonatal immunization. J Infect Dis. May 15 2008;197(10):1419–26. doi:10.1086/587695.
   PubMed Web of Science ®Google Scholar
• Jan CF, Huang KC, Chien YC, Greydanus DE, Davies HD, Chiu T-Y, Huang L-M, Chen C-J, Chen D-S. Determination of immune memory to hepatitis B vaccination through early booster response in college students. Hepatology. 2010;51(5):1547–54. doi:10.1002/hep.23543.
   PubMed Web of Science ®Google Scholar
• van der Sande MA, Waight P, Mendy M, Rayco‐solon P, Hutt P, Fulford T, Doherty C, McConkey S&, Jeffries D, Hall A&, et al. Long-Term protection against carriage of hepatitis B virus after infant vaccination. J Infect Dis. 2006;193(11):1528–35. doi:10.1086/503433.
   PubMed Web of Science ®Google Scholar
• Chang MH. Breakthrough HBV infection in vaccinated children in Taiwan: surveillance for HBV mutants. Antivir Ther. 2010;15(3 Pt B):463–69. doi:10.3851/imp1555.
   PubMed Web of Science ®Google Scholar
• WHO. Evidence to recommendations table and GRADE table, need for a hepatitis B vaccine booster dose following primary immunization. http://who.int/immunization/policy/position_papers/hepatitis_b/evidence_recommendation_gratable_hepb_duration.pdf2017 .
   Google Scholar
• Yang S, Tian G, Cui Y, Ding C, Deng M, Yu C, Xu K, Ren J, Yao J, Li Y, et al. Factors influencing immunologic response to hepatitis B vaccine in adults. Sci Rep. Jun 21 2016;6:27251. doi:10.1038/srep27251.
   PubMed Web of Science ®Google Scholar
• Schillie S, Harris A, Link-Gelles R, Romero J, Ward J, Nelson N. Recommendations of the advisory committee on immunization practices for use of a hepatitis B vaccine with a novel adjuvant. MMWR Morb Mortal Wkly Rep. 2018;67(15):455–58. doi:10.15585/mmwr.mm6715a5.
   PubMed Web of Science ®Google Scholar
• Ruggieri A, Gagliardi MC, Anticoli S. Sex-Dependent outcome of hepatitis B and C viruses infections: synergy of sex hormones and immune responses? Front Immunol. 2018;9:2302. doi:10.3389/fimmu.2018.02302.
   PubMed Web of Science ®Google Scholar
• Tsay PK, Tai DI, Chen YM, Yu C-P, Wan S-Y, Shen Y-J, Lin D-Y. Impact of gender, viral transmission and aging in the prevalence of hepatitis B surface antigen. Chang Gung Med J. 2009;32(2):155–64.
   PubMedGoogle Scholar
• Louie JK, Acosta M, Winter K, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. Jama. 2009;302(17):1896–902. doi:10.1001/jama.2009.1583.
   PubMed Web of Science ®Google Scholar
• Liu F, Guo Z, Dong C. Influences of obesity on the immunogenicity of hepatitis B vaccine. Hum Vaccines Immunother. 2017;13(5):1014–17. doi:10.1080/21645515.2016.1274475.
   PubMed Web of Science ®Google Scholar
• White SJ, Taylor MJ, Hurt RT, Jensen MD, Poland GA. Leptin-Based adjuvants: an innovative approach to improve vaccine response. Vaccine. Mar 25 2013;31(13):1666–72. doi:10.1016/j.vaccine.2013.01.032.
   PubMed Web of Science ®Google Scholar
• Krist AH, Davidson KW, Mangione CM, Barry MJ, Cabana M, Caughey AB, Donahue K, Doubeni CA, Epling JW, Kubik M, et al. Screening for hepatitis B virus infection in adolescents and adults: US preventive services task force recommendation statement. Jama. 2020;324(23):2415–22. doi:10.1001/jama.2020.22980.
   PubMed Web of Science ®Google Scholar